Aureus Asset Management LLC Lowers Holdings in HealthEquity, Inc. $HQY

Aureus Asset Management LLC trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 24.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 219,664 shares of the company’s stock after selling 72,039 shares during the period. HealthEquity accounts for about 1.3% of Aureus Asset Management LLC’s portfolio, making the stock its 27th largest position. Aureus Asset Management LLC’s holdings in HealthEquity were worth $20,123,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in HQY. William Blair Investment Management LLC purchased a new position in shares of HealthEquity in the fourth quarter valued at about $169,956,000. Norges Bank purchased a new position in shares of HealthEquity in the fourth quarter valued at about $66,927,000. AQR Capital Management LLC lifted its position in shares of HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after acquiring an additional 661,795 shares in the last quarter. Cadian Capital Management LP purchased a new position in shares of HealthEquity in the fourth quarter valued at about $51,915,000. Finally, Northwestern Mutual Wealth Management Co. lifted its position in shares of HealthEquity by 229,985.6% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 478,578 shares of the company’s stock valued at $43,843,000 after acquiring an additional 478,370 shares in the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, EVP Delano Ladd sold 7,500 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the transaction, the executive vice president owned 91,141 shares of the company’s stock, valued at $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. This trade represents a 11.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 13,081 shares of company stock valued at $1,193,000. 1.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on HQY shares. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. KeyCorp restated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $85.00 to $105.00 in a research report on Thursday, April 9th. Barrington Research reiterated an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. Finally, JPMorgan Chase & Co. decreased their target price on HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus price target of $110.57.

HealthEquity Trading Up 0.8%

Shares of HQY stock opened at $86.33 on Thursday. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $106.60. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The stock’s 50 day simple moving average is $84.76 and its two-hundred day simple moving average is $85.35. The company has a market cap of $7.22 billion, a PE ratio of 32.33, a price-to-earnings-growth ratio of 1.44 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.